Is size the next big thing in epidemiology?

Epidemiology. 2013 May;24(3):349-51. doi: 10.1097/EDE.0b013e31828ac65e.
No abstract available

MeSH terms

  • Amides / adverse effects
  • Angioedema / chemically induced
  • Angiotensin Receptor Antagonists / adverse effects
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects
  • Antihypertensive Agents / adverse effects
  • Data Interpretation, Statistical
  • Databases, Factual* / economics
  • Epidemiologic Research Design*
  • Fumarates / adverse effects
  • Humans
  • Multicenter Studies as Topic / economics
  • Multicenter Studies as Topic / methods*
  • Product Surveillance, Postmarketing / economics
  • Product Surveillance, Postmarketing / methods*
  • Research Support as Topic
  • United States

Substances

  • Amides
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Fumarates
  • aliskiren